tiprankstipranks
Trending News
More News >
Teva Pharmaceutical Industries Limited (IL:TEVA)
:TEVA
Israel Market

Teva (TEVA) Stock Forecast & Price Target

Compare
13 Followers
See the Price Targets and Ratings of:

TEVA Financial Forecast

TEVA Earnings Forecast

Next quarter’s earnings estimate for TEVA is 227.80 with a range of 209.00 to 251.10. The previous quarter’s EPS was 186.50. TEVA beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 26.32% of the time in the same period. In the last calendar year TEVA has Outperformed its overall industry.
Next quarter’s earnings estimate for TEVA is 227.80 with a range of 209.00 to 251.10. The previous quarter’s EPS was 186.50. TEVA beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 26.32% of the time in the same period. In the last calendar year TEVA has Outperformed its overall industry.

TEVA Sales Forecast

Next quarter’s sales forecast for TEVA is 1.56T with a range of 1.52T to 1.61T. The previous quarter’s sales results were 1.40T. TEVA beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 76.00% of the time in the same period. In the last calendar year TEVA has Outperformed its overall industry.
Next quarter’s sales forecast for TEVA is 1.56T with a range of 1.52T to 1.61T. The previous quarter’s sales results were 1.40T. TEVA beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 76.00% of the time in the same period. In the last calendar year TEVA has Outperformed its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leader Capital Markets Analyst forecast on IL:TEVA
Sabina LeviLeader Capital Markets
Leader Capital Markets
10,710
Buy
75.60%
Upside
Initiated
01/30/25
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leader Capital Markets Analyst forecast on IL:TEVA
Sabina LeviLeader Capital Markets
Leader Capital Markets
10,710
Buy
75.60%
Upside
Initiated
01/30/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Teva

1 Month
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-7.30%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -7.30% per trade.
3 Months
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-11.05%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -11.05% per trade.
1 Year
Sabina LeviLeader Capital Markets
Success Rate
0/2 ratings generated profit
0%
Average Return
-7.70%
reiterated a buy rating 18 days ago
Copying Sabina Levi's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -7.70% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-7.20%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -7.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TEVA Analyst Recommendation Trends

Rating
Dec 24
Jan 25
May 25
Strong Buy
0
1
1
Buy
1
1
2
Hold
0
0
0
Sell
0
0
0
Strong Sell
0
0
0
total
1
2
3
In the current month, TEVA has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TEVA average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

TEVA Stock Forecast FAQ

What is IL:TEVA’s average 12-month price target, according to analysts?
Currently, no data Available
What is IL:TEVA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IL:TEVA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Teva Pharmaceutical Industries Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Teva Pharmaceutical Industries Limited’s share price target?
      Currently, no data Available
      What do analysts say about Teva Pharmaceutical Industries Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Teva Pharmaceutical Industries Limited?
      To buy shares of IL:TEVA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis